In parallel, we have analyzed the oncogenic transcription factor c-MYC expression, which has recently been shown to be a target of both BTK [26, 27] and NOTCH1 [24, 25] pathways in different hematological malignancies, including B-CLL. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.